PROQR THERAPEUTICS EO-04 (0PQ) — Financial Flexibility Index
PROQR THERAPEUTICS EO-04 (0PQ) has a Financial Flexibility Index of -0.20x as of December 2025. Free cash flow of €-12.83 Million (operating CF €-13.36 Million minus capex €526.00K) represents 0% of total liabilities (€63.38 Million). Check total reinvestment intensity of PROQR THERAPEUTICS EO-04 to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
PROQR THERAPEUTICS EO-04 Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for PROQR THERAPEUTICS EO-04 across 5 annual periods. For the full cash flow conversion analysis, see cash flow conversion of PROQR THERAPEUTICS EO-04.
Annual Financial Flexibility Index for PROQR THERAPEUTICS EO-04 (2021–2025)
Year-by-year free cash flow to debt coverage for PROQR THERAPEUTICS EO-04. Explore PROQR THERAPEUTICS EO-04 cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.82x | €-51.77 Million | €-52.79 Million | €63.38 Million | ▼ -85.4% |
| 2024 | -0.44x | €-34.98 Million | €-36.39 Million | €79.40 Million | ▼ -285.5% |
| 2023 | 0.24x | €22.92 Million | €21.55 Million | €96.49 Million | ▲ +136.7% |
| 2022 | -0.65x | €-67.80 Million | €-68.51 Million | €104.64 Million | ▼ -144.5% |
| 2021 | -0.26x | €-25.53 Million | €-26.01 Million | €96.35 Million | — |